AU2001273941A1 - Ciprofloxacin infusion solutions having a good storage stability - Google Patents
Ciprofloxacin infusion solutions having a good storage stabilityInfo
- Publication number
- AU2001273941A1 AU2001273941A1 AU2001273941A AU7394101A AU2001273941A1 AU 2001273941 A1 AU2001273941 A1 AU 2001273941A1 AU 2001273941 A AU2001273941 A AU 2001273941A AU 7394101 A AU7394101 A AU 7394101A AU 2001273941 A1 AU2001273941 A1 AU 2001273941A1
- Authority
- AU
- Australia
- Prior art keywords
- storage stability
- good storage
- infusion solutions
- ciprofloxacin
- ciprofloxacin infusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title 2
- 229960003405 ciprofloxacin Drugs 0.000 title 1
- 239000003978 infusion fluid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10018783A DE10018783A1 (en) | 2000-04-15 | 2000-04-15 | Stable aqueous ciprofloxacin infusion solutions containing sulfuric acid as the stabilizing agent useful for the treatment of bacterial infections in humans and animals |
DE10018783 | 2000-04-15 | ||
PCT/EP2001/004163 WO2001078732A1 (en) | 2000-04-15 | 2001-04-11 | Ciprofloxacin infusion solutions having a good storage stability |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001273941A1 true AU2001273941A1 (en) | 2001-10-30 |
Family
ID=7638903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001273941A Abandoned AU2001273941A1 (en) | 2000-04-15 | 2001-04-11 | Ciprofloxacin infusion solutions having a good storage stability |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001273941A1 (en) |
DE (1) | DE10018783A1 (en) |
WO (1) | WO2001078732A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10048510A1 (en) * | 2000-09-29 | 2002-05-16 | Fresenius Kabi De Gmbh | Storage-stable infusion solution of ciprofloxacin with reduced acidity |
US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
DE102004005186B3 (en) * | 2004-02-02 | 2005-10-13 | Krka Tovarna Zdravil, D.D. | Process for the preparation of purified ciprofloxacin |
DE102004029784A1 (en) | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel 2-Benzylaminodihydropteridinones, process for their preparation and their use as medicaments |
DE102004033670A1 (en) | 2004-07-09 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New pyridodihydropyrazinone, process for its preparation and its use as a medicament |
US20060058311A1 (en) | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
US7728134B2 (en) | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
US20060035903A1 (en) * | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
US20060074088A1 (en) | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
EP1630163A1 (en) | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinones, methods for their preparation and their use as drugs |
DE102004058337A1 (en) | 2004-12-02 | 2006-06-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the preparation of fused piperazin-2-one derivatives |
US7439358B2 (en) | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
EP3098223A1 (en) | 2007-08-03 | 2016-11-30 | Boehringer Ingelheim International GmbH | Crystalline form of a dihydropteridione derivative |
US8546566B2 (en) | 2010-10-12 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
US9358233B2 (en) | 2010-11-29 | 2016-06-07 | Boehringer Ingelheim International Gmbh | Method for treating acute myeloid leukemia |
US9370535B2 (en) | 2011-05-17 | 2016-06-21 | Boehringer Ingelheim International Gmbh | Method for treatment of advanced solid tumors |
JP2016525532A (en) | 2013-07-26 | 2016-08-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Treatment of myelodysplastic syndrome |
US9867831B2 (en) | 2014-10-01 | 2018-01-16 | Boehringer Ingelheim International Gmbh | Combination treatment of acute myeloid leukemia and myelodysplastic syndrome |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3537761A1 (en) * | 1985-10-24 | 1987-04-30 | Bayer Ag | INFUSION SOLUTIONS OF 1-CYCLOPROPYL-6-FLUOR-1,4-DIHYDRO-4-OXO-7- (1-PIPERAZINYL) -QUINOLINE-3-CARBONIC ACID |
WO1990001933A1 (en) * | 1988-08-26 | 1990-03-08 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
-
2000
- 2000-04-15 DE DE10018783A patent/DE10018783A1/en not_active Ceased
-
2001
- 2001-04-11 WO PCT/EP2001/004163 patent/WO2001078732A1/en active Application Filing
- 2001-04-11 AU AU2001273941A patent/AU2001273941A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001078732A1 (en) | 2001-10-25 |
DE10018783A1 (en) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273941A1 (en) | Ciprofloxacin infusion solutions having a good storage stability | |
AU2002224520A1 (en) | A cannula | |
AU2001248831A1 (en) | Liquid storage bag | |
AU2002218802A1 (en) | Secure transactions with passive storage media | |
AU2001275095A1 (en) | Single-patient drug trials used with accumulated database | |
AU4570600A (en) | Storage media | |
AU2001281852A1 (en) | Highly concentrated stable meloxicam solutions | |
AUPR054400A0 (en) | A castor | |
AU2001280598A1 (en) | Anti-occlusion catheter | |
AU2001278892A1 (en) | Storage rack shelving | |
AU1412600A (en) | Needle unit storage case | |
AU4509301A (en) | Volume stacking model | |
AUPR000100A0 (en) | Ammonia storage | |
AUPR197400A0 (en) | Data storage | |
AU1412500A (en) | Injection syringe storage case | |
AU2002222351A1 (en) | Managing a medical procedure | |
AU2001284194A1 (en) | Storage facility | |
AU2002361181A1 (en) | Shaped body containing agents with increased storage stability | |
AU2001260198A1 (en) | Ciprofloxacin infusion solutions with improved storage life | |
AU2001275913A1 (en) | A sleeping chair | |
AU2002214990A1 (en) | Storage device | |
AU2000246167A1 (en) | Biodegradable infusion set | |
AUPR050000A0 (en) | Mower | |
AUPQ864900A0 (en) | A syringe | |
AUPQ831400A0 (en) | Storage solutions |